Tag: intragastric balloons market scope

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Intragastric Balloons Market Size, Value And Growth Trajectory Through 2030#_x000D_

The intragastric balloons market has expanded significantly over recent years. It is projected to expand from $22.05 billion in 2025 to $24.55 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. The historical expansion can be attributed to several factors, including the increasing global incidence of obesity, heightened awareness of weight management solutions, the growing limitations of lifestyle-based weight loss methods, the expansion of bariatric and endoscopic services, and a rising inclination towards minimally invasive treatments._x000D_

_x000D_

The intragastric balloons market is anticipated to observe significant expansion in the coming years. It is projected to reach $36.1 billion by 2030, advancing at a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is primarily driven by an escalating demand for non-invasive obesity treatments, a rise in obesity-related health complications, an increased focus on preventative weight management strategies, the broadening availability of endoscopic bariatric procedures, and a growing patient preference for reversible weight loss options. Noteworthy developments expected in the forecast period include the increasing adoption of non-surgical weight loss interventions, a rising preference for temporary and reversible bariatric solutions, the expanded application of intragastric balloons for pre-operative weight reduction, the further integration of intragastric balloon therapy within obesity management programs, and the growing acceptance of endoscopic weight loss techniques._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=93565881&type=smp&name=Intragastric%20Balloons%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Intragastric Balloons Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_

Rising obesity levels are anticipated to fuel the expansion of the intragastric balloon market in the future. Obesity rates signify the proportion of a population classified as obese, determined by body mass index (BMI) scores, typically defined as a BMI of 30 or more. The rise in obesity rates stems from various factors including dietary patterns, inactive lifestyles, economic influences, advertising and marketing strategies, genetic and biological predispositions, psychological and emotional aspects, and changes in urbanization and infrastructure. Individuals suffering from obesity use intragastric balloons as a non-invasive method for weight reduction, as these devices fill stomach space, thereby inducing satiety and decreasing overall food consumption. As an illustration, data from March 2023, sourced from the World Obesity Atlas 2022, released by the UK-based non-profit organization, the World Obesity Federation, indicates that the worldwide economic burden of overweight and obesity is forecast to hit $4.32 trillion annually by 2035, assuming current prevention and treatment approaches persist. By the same year, more than half of the global population (51%, amounting to over 4 billion people) could be living with overweight or obesity, and nearly 2 billion individuals, or 1 in 4 people, are anticipated to be obese if current patterns persist. Consequently, the growing prevalence of obesity is propelling the expansion of the intragastric balloon market._x000D_

_x000D_

#Intragastric Balloons Market Segments: Where Is Growth Concentrated?#_x000D_

The intragastric balloons market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Single, Dual, Triple Intragastric Balloons_x000D_

2) By Filling Material: Saline Filled, Gas Filled_x000D_

3) By Application Areas: Obesity, Weight-loss, Pre-operative Weight Reduction, Other Applications_x000D_

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon_x000D_

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon_x000D_

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon_x000D_

_x000D_

#Intragastric Balloons Market Growth Trends: What’s Shaping The Future Outlook?_x000D_

Leading companies in the intragastric balloon market are innovating advanced remedies, including weight loss drugs, to confront issues such as the challenges of dieting, expense, and the apprehension of surgical operations. Weight loss medications aid in diminishing body weight by suppressing hunger, accelerating metabolism, or hindering fat absorption. For example, in August 2025, Boston Scientific launched Endura Weight Loss Solutions, presenting minimally invasive, endoscopic alternatives to surgical interventions or ongoing medication. These offerings encompass endoscopic sleeve gastroplasty (ESG), which decreases stomach volume by 70–80% through internal suturing, and the Orbera Intragastric Balloon System, which fosters a sensation of fullness by implanting a balloon in the stomach. These outpatient interventions assist patients in consuming less, feeling satiated more quickly, and achieving a swift recovery, thereby providing a secure and efficacious choice for individuals with moderate obesity or those unable to undergo surgery, especially when integrated with lifestyle modifications for complete obesity management._x000D_

_x000D_

#Intragastric Balloons Market Company Landscape And Competitive Strategy#_x000D_

Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies _x000D_

_x000D_

#View The Full Intragastric Balloons Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Intragastric Balloons Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_

North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Intragastric Balloons Market Progress Through 2030?

The intragastric balloons market has experienced significant expansion in its size over recent years. This market is projected to expand from $22.05 billion in 2025 to $24.55 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. Historically, this expansion has been driven by factors such as the global increase in obesity, greater understanding of weight management options, the increasing inadequacy of lifestyle-driven weight loss strategies, the growth of bariatric and endoscopic services, and a growing inclination towards treatments that are less invasive.

The intragastric balloons market is projected for significant expansion in the coming years. This market is anticipated to reach a valuation of $36.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors driving this expansion during the forecast period include the escalating demand for non-invasive obesity solutions, a rising prevalence of health conditions linked to obesity, a heightened emphasis on proactive weight control, the wider availability of endoscopic bariatric interventions, and an increasing patient inclination towards reversible methods for weight loss. Key trends observed within this period encompass the increasing acceptance of non-surgical approaches to weight reduction, a growing preference for temporary and reversible bariatric therapies, the expanded application of intragastric balloons for pre-surgical weight loss, the broader integration of intragastric balloon therapy into obesity management programs, and the increasing embrace of endoscopic weight loss procedures.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What Influential Factors Are Boosting The Intragastric Balloons Market Demand?

Rising obesity levels are anticipated to drive the expansion of the intragastric balloon market in the future. Obesity rates indicate the proportion of a population classified as obese according to body mass index (BMI) measurements, typically defined as a BMI of 30 or greater. The increase in obesity is linked to factors such as dietary choices, inactive lifestyles, economic conditions, promotional activities, genetic and biological predispositions, psychological and emotional aspects, and urban development and infrastructure. Intragastric balloons offer a non-surgical solution for obese individuals to assist with weight reduction, working by filling stomach space, fostering a sensation of satiety, and thereby decreasing food consumption. For example, data from March 2023, sourced from the World Obesity Atlas 2022, a publication by the UK-based non-profit World Obesity Federation, predicts that the worldwide economic cost of overweight and obesity could hit $4.32 trillion annually by 2035 if current prevention and treatment strategies persist. At that point, more than half of the global populace (51%, exceeding 4 billion individuals) might be impacted by overweight or obesity, with almost 2 billion people, equivalent to 1 in 4, anticipated to be obese if present trends continue. Consequently, the escalating obesity rates are fueling the expansion of the intragastric balloon market.

How Does Segment Analysis Break Down The Intragastric Balloons Market Structure?

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Application Areas: Obesity, Weight-loss, Pre-operative Weight Reduction, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Trends Are Affecting The Growth Of The Intragastric Balloons Market?

Prominent companies in the intragastric balloon market are innovating advanced solutions, including weight loss medications, to tackle issues such as dieting struggles, financial burdens, and apprehension of surgical procedures. Weight loss medications aid in lowering body weight by suppressing hunger, enhancing metabolism, or restricting fat absorption. For example, in August 2025, Boston Scientific unveiled Endura Weight Loss Solutions, presenting minimally invasive, endoscopic alternatives to surgery or continuous medication. These options encompass endoscopic sleeve gastroplasty (ESG), which decreases stomach volume by 70–80% through internal sutures, and the Orbera Intragastric Balloon System, which fosters satiety by inserting a balloon into the stomach. These outpatient interventions assist patients in consuming less, feeling full sooner, and experiencing swift recuperation, offering a secure and efficient choice for individuals with moderate obesity or those not suitable for surgery, when coupled with lifestyle adjustments for thorough obesity management.

Who Are The Firms Contributing To The Intragastric Balloons Market Ecosystem?

Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies

Access The Complete Intragastric Balloons Market Report:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Regional Market Leads The Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Intragastric Balloons Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Self Expanding Stents Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report

Drug Eluting Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Intragastric Balloons Market In 2026 And 2030?

The intragastric balloons market has experienced significant expansion in recent years. It is forecast to increase from $22.05 billion in 2025 to $24.55 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. Historically, this growth has been driven by the rising global prevalence of obesity, increased awareness concerning weight management solutions, the evolving limitations of lifestyle-based weight loss methods, the expansion of bariatric and endoscopic services, and a growing preference for minimally invasive treatments.

The market for intragastric balloons is anticipated to experience swift expansion over the coming years. This market is projected to reach $36.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. The forecasted expansion is driven by several factors, including a heightened demand for non-surgical approaches to obesity, a rising occurrence of health issues linked to obesity, a greater emphasis on proactive weight management, wider access to endoscopic bariatric procedures, and a growing patient inclination towards reversible weight loss solutions. Significant trends anticipated during this period encompass a broader embrace of non-surgical weight loss methods, an increasing favorability for temporary and reversible bariatric therapies, a surge in the application of intragastric balloons for weight reduction prior to surgery, an increased integration of intragastric balloon therapy within obesity management strategies, and a growing acceptance of endoscopic interventions for weight loss.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

Which Strong Drivers Are Impacting The Intragastric Balloons Market Growth?

The future expansion of the intragastric balloon market is anticipated to be driven by a rise in obesity rates. Obesity rates indicate the proportion of a population classified as obese, typically defined by a Body Mass Index (BMI) of 30 or greater. This escalation in obesity is attributed to various factors including dietary practices, inactive lifestyles, economic conditions, promotional strategies, genetic and biological predispositions, psychological and emotional influences, and urban development. For weight management, individuals struggling with obesity often turn to intragastric balloons, a non-surgical solution that helps by filling space in the stomach, thus fostering satiety and decreasing overall food consumption. For example, reports from March 2023 by the UK-based World Obesity Federation’s World Obesity Atlas 2022 predict that the worldwide financial burden of overweight and obesity could hit $4.32 trillion annually by 2035, assuming current prevention and treatment strategies persist. Should these trends continue, by the same year, over half of the global populace, specifically 51% or more than 4 billion individuals, might suffer from overweight or obesity, with nearly 2 billion people, or 1 in 4, anticipated to be classified as obese. Consequently, the rising prevalence of obesity is a key factor propelling the expansion of the intragastric balloon market.

What Segment Categories Shape The Intragastric Balloons Market Segment Landscape?

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Application Areas: Obesity, Weight-loss, Pre-operative Weight Reduction, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

Which Trends Are Contributing To Changes In The Intragastric Balloons Market?

Leading companies in the intragastric balloon sector are developing advanced solutions, including weight loss medications, to tackle challenges such as difficulties with dieting, associated costs, and the fear of surgical procedures. These weight loss medications contribute to reducing body weight by suppressing appetite, enhancing metabolism, or limiting the absorption of fat. For example, Boston Scientific introduced Endura Weight Loss Solutions in August 2025, providing minimally invasive, endoscopic alternatives to surgery or long-term drug therapies. These solutions encompass endoscopic sleeve gastroplasty (ESG), which lessens stomach volume by 70–80% through internal stitching, and the Orbera Intragastric Balloon System, which fosters a sense of fullness by placing a balloon inside the stomach. These outpatient procedures assist patients in eating less, feeling satisfied sooner, and recovering quickly, offering a safe and effective choice for individuals with moderate obesity or those unable to undergo surgery, especially when combined with lifestyle adjustments for thorough obesity management.

Who Are The Companies Operating Across The Intragastric Balloons Market Value Chain?

Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies

Get The Full Intragastric Balloons Market Report:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Region Holds The Highest Market Share In The Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Intragastric Balloons Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Self Expanding Stents Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report

Drug Eluting Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Intragastric Balloons Market During The Forecast Period 2026–2030?

The intragastric balloons market size has experienced rapid growth in recent years. It is projected to expand from $22.05 billion in 2025 to $24.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.4%. The increase observed in the past period can be linked to the rising prevalence of obesity worldwide, increasing awareness of weight management solutions, growing limitations associated with lifestyle-based weight loss methods, the expansion of bariatric and endoscopic services, and a rising preference for minimally invasive treatments.

The intragastric balloons market is anticipated to experience substantial growth over the coming years, reaching $36.1 billion in 2030 with a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is fueled by factors such as a rising demand for non-surgical treatments for obesity, a growing occurrence of health issues linked to obesity, an increased emphasis on proactive weight management, the broader availability of endoscopic bariatric procedures, and a greater patient inclination towards reversible weight loss solutions. Significant trends for this period include the increasing uptake of non-surgical weight loss interventions, a rising preference for temporary and reversible bariatric therapies, the expanded application of intragastric balloons for pre-operative weight reduction, the wider integration of intragastric balloon therapy in obesity management programs, and the increasing acceptance of endoscopic approaches for weight loss.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

Which Economic Or Industry Drivers Are Impacting The Intragastric Balloons Market?

Rising obesity levels are anticipated to fuel the expansion of the intragastric balloon market in the future. Obesity rates indicate the proportion of a population classified as obese, typically characterized by a Body Mass Index (BMI) of 30 or greater. This rise in obesity is attributed to various factors including dietary patterns, inactive lifestyles, economic conditions, promotional activities, genetic and biological predispositions, psychological and emotional influences, and urban development. For individuals with obesity, intragastric balloons offer a non-surgical weight loss solution by filling stomach space, thereby inducing satiety and decreasing food consumption. A notable example comes from the World Obesity Atlas 2022, released in March 2023 by the UK-based World Obesity Federation, which projects the worldwide economic burden of overweight and obesity to hit $4.32 trillion annually by 2035, assuming current prevention and treatment strategies persist. This report also predicts that more than half of the global population (51%, or over 4 billion individuals) could be overweight or obese by then, with almost 2 billion people (1 in 4) likely to be obese if present trends persist. Consequently, the growing prevalence of obesity is a key factor stimulating the expansion of the intragastric balloon market.

What Market Segments Are Evaluated Within The Intragastric Balloons Market?

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Application Areas: Obesity, Weight-loss, Pre-operative Weight Reduction, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Industry Trends Are Redefining The Intragastric Balloons Market?

Leading companies in the intragastric balloon market are developing advanced solutions, including weight loss medications, to address challenges such as difficulties with dieting, high costs, and the fear of surgery. Weight loss medications aid in reducing body weight by curbing appetite, boosting metabolism, or limiting fat absorption. For instance, in August 2025, Boston Scientific introduced Endura Weight Loss Solutions, offering minimally invasive, endoscopic alternatives to surgical procedures or long-term drug therapy. These include endoscopic sleeve gastroplasty (ESG), which reduces stomach volume by 70–80% through internal stitching, and the Orbera Intragastric Balloon System, which promotes a feeling of fullness by placing a balloon in the stomach. These outpatient procedures help patients eat less, feel satiated more quickly, and recover rapidly, providing a safe and effective option for individuals with moderate obesity or those ineligible for surgery, especially when combined with lifestyle changes for comprehensive obesity management.

Who Are The Top Market Participants Influencing The Intragastric Balloons Market?

Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies

Read the full intragastric balloons market report here:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

What Are The Top-Performing Regions Within The Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Intragastric Balloons Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Self Expanding Stents Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report

Drug Eluting Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Intragastric Balloons Market covering 2026–2035?

The intragastric balloons market size has experienced rapid expansion in recent years. Forecasts indicate that the market will expand from $22.05 billion in 2025 to $24.55 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. This historical growth is primarily driven by factors such as the increasing global prevalence of obesity, greater recognition of weight management options, the increasing inadequacy of lifestyle-focused weight loss approaches, the expansion of bariatric and endoscopic healthcare services, and a growing inclination towards less invasive treatment methods.

The intragastric balloons market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $36.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the forecast period include a rising demand for non-surgical approaches to obesity, a greater occurrence of conditions linked to obesity, an increased emphasis on proactive weight management, wider access to endoscopic bariatric interventions, and a growing patient inclination towards reversible weight loss solutions. Key trends foreseen for this period encompass the increasing acceptance of non-surgical methods for weight loss, a heightened preference for temporary and reversible bariatric therapies, the expanding application of intragastric balloons for reducing weight prior to surgery, the broader integration of intragastric balloon therapy within obesity management strategies, and the growing embrace of endoscopic weight loss procedures.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Intragastric Balloons Market?

The increasing prevalence of obesity is anticipated to propel the growth of the intragastric balloon market. Obesity rates signify the percentage of a population considered obese based on Body Mass Index (BMI) measurements, typically defined as a BMI of 30 or higher. This rise in obesity is attributed to various factors including dietary habits, sedentary lifestyles, economic conditions, advertising and marketing strategies, genetics and biology, psychological and emotional aspects, and urbanization and infrastructure developments. Obese individuals opt for intragastric balloons as a non-surgical method to facilitate weight loss by occupying space within the stomach, thereby promoting a feeling of fullness and reducing food intake. For example, in March 2023, the World Obesity Atlas 2022, published by the UK-based non-profit organization World Obesity Federation, projected that the global economic impact of overweight and obesity could reach $4.32 trillion per year by 2035 if current prevention and treatment efforts remain unchanged. By that time, over half of the world’s population (51%, or more than 4 billion people) may be affected by overweight or obesity, with nearly 2 billion individuals, or 1 in 4 people, expected to have obesity if present trends persist. Consequently, the rising obesity rates are a key driver for the growth of the intragastric balloon market.

What Segments Are Identified Within The Structure Of The Intragastric Balloons Market?

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Application Areas: Obesity, Weight-loss, Pre-operative Weight Reduction, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

Which Market Trends Are Opening Growth Opportunities In The Intragastric Balloons Market?

Leading companies in the intragastric balloon market are developing advanced solutions, including weight loss medications, to address challenges like dieting difficulties, costs, and fear of surgery. Weight loss medications aid in reducing body weight by curbing appetite, boosting metabolism, or limiting fat absorption. For instance, in August 2025, Boston Scientific introduced Endura Weight Loss Solutions, providing minimally invasive, endoscopic alternatives to surgery or long-term medication. These encompass endoscopic sleeve gastroplasty (ESG), which reduces stomach volume by 70–80% through internal stitching, and the Orbera Intragastric Balloon System, which encourages fullness by placing a balloon in the stomach. These outpatient procedures assist patients in eating less, feeling full more quickly, and recovering rapidly, offering a safe and effective option for moderate obesity or those ineligible for surgery, when combined with lifestyle changes for comprehensive obesity management.

Which Major Industry Participants Are Leading The Intragastric Balloons Market Growth?

Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Region Is Projected To Lead The Intragastric Balloons Market During The Forecast Period?

North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intragastric Balloons Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2026, By The Business Research Company

Vascular Stent Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Self Expanding Stents Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report

Drug Eluting Stent Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the intragastric balloons market from 2025–2034 with trusted insights from The Business Research Company

How Will The Intragastric Balloons Market Size Evolve Between Now And 2029?

The intragastric balloons market has seen substantial growth in recent years. It is anticipated to increase from $19.89 billion in 2024 to $22.05 billion in 2025, progressing at a compound annual growth rate (CAGR) of 10.9%. This historical expansion can be attributed to several factors such as increasing obesity rates, greater healthcare expenditure, available clinical evidence and FDA approvals, effective awareness campaigns, enhancements in balloon designs, and the expansion of medical tourism.

The intragastric balloons market is projected to experience swift expansion over the coming years. This market is forecast to reach a valuation of $33.15 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.7%. The anticipated growth during this period is primarily driven by factors such as celebrity endorsements, rising concerns over obesity-related health problems, market expansion into developing regions, a surge in endoscopic procedures, the increasing demographic of an aging population, and the adoption of personalized treatment strategies. Key trends expected over the forecast horizon encompass technological advancements, increased awareness disseminated via social media, the incorporation of digital health platforms, applications of artificial intelligence, the prevalence of virtual consultations, and improved patient education initiatives.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

Which Key Drivers Are Powering Growth In The Intragastric Balloons Market?

Rising obesity rates are anticipated to propel the growth of the intragastric balloon market going forward. Obesity rates indicate the prevalence or percentage of a population considered obese based on body mass index (BMI) measurements, typically defined as having a BMI of 30 or higher. The increase in obesity is attributed to factors such as dietary habits, sedentary lifestyles, economic factors, advertising and marketing, genetics and biology, psychological and emotional factors, and urbanization and infrastructure. Obese individuals utilize intragastric balloons as a non-surgical option to assist in weight loss by occupying space in the stomach, thereby promoting feelings of fullness and reducing food intake. For instance, in March 2023, according to the World Obesity Atlas 2022, published by the World Obesity Federation, a UK-based non-profit organization, the global economic impact of overweight and obesity is projected to reach $4.32 trillion per year by 2035 if prevention and treatment efforts remain unchanged. By that time, over half of the world’s population (51%, or more than 4 billion people) could be affected by overweight or obesity, with nearly 2 billion individuals—1 in 4 people—expected to have obesity if current trends continue. Therefore, the increasing obesity rates are driving the growth of the intragastric balloon market.

How Is The Global Intragastric Balloons Market Structured By Key Segments?

The intragastric balloonsmarket covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Future-Focused Trends Are Anticipated In The Intragastric Balloons Market?

Leading companies in the intragastric balloon market are concentrating on developing advanced medical weight-loss devices, specifically swallowable gastric balloons, to improve patient comfort, usability, and access. These swallowable gastric balloons are non-surgical instruments that assist in weight loss by temporarily occupying space in the stomach, thereby promoting a sensation of fullness and decreasing food intake. For example, in September 2022, Allurion Technologies Inc., a medical device company based in the US, introduced a swallowable gastric balloon capsule in India. This groundbreaking device is the world’s first non-surgical swallowable gastric balloon that does not necessitate endoscopy or anesthesia for its insertion or removal. The Allurion gastric balloon capsule presents a safe, non-surgical, and effective option for weight loss, designed to help individuals achieve notable weight reduction and embrace healthier lifestyle practices for enduring success.

Which Companies Hold A Competitive Edge In The Intragastric Balloons Market?

Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd., American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc., Inamed Health, Medsil, Obalon Therapeutics Inc., Endalis, Lexel SRL

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Region Is Expected To Lead The Intragastric Balloons Market In The Next Few Years?

North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Intragastric Balloons Market From 2025 To 2034?

The market for intragastric balloons has experienced an accelerated expansion lately; projections indicate a rise from a valuation of $19.89 billion in 2024 to $22.05 billion in 2025, reflecting a ten-point-nine percent compound annual growth rate over that span. This upward trajectory in the past duration is assignable to several interconnected factors, including escalating obesity prevalence, increased spending on healthcare services, the accrual of supporting clinical data alongside the attainment of FDA authorizations, proactive public awareness initiatives, enhancements in balloon engineering, and burgeoning medical tourism activities.

Anticipating substantial expansion, the market for intragastric balloons is projected to reach a valuation of $33.15 billion by the year 2029, exhibiting a consistent compound annual growth rate of 10.7% throughout the coming years; this upward trajectory is propelled by factors such as endorsements from public figures, the rising prevalence of health concerns linked to weight, market penetration in developing economies, a greater frequency of endoscopic interventions, demographic shifts toward an older populace, and the adoption of customized treatment modalities, while key developments shaping this period involve advancements in technology, greater visibility fostered by social media engagement, the interconnectivity with digital healthcare systems, the incorporation of artificial intelligence, remote consultation opportunities, and more comprehensive patient educational initiatives.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What Are The Top Growth Drivers Impacting The Intragastric Balloons Market Outlook?

Elevated occurrences of obesity are anticipated to stimulate the expansion of the intragastric balloon sector in the foreseeable future.Obesity prevalence signifies the proportion or count within a populace classified as obese, typically determined by a Body Mass Index (BMI) reaching 30 or exceeding that value.Factors contributing to the rise in obesity encompass shifts in eating patterns, limited physical activity, financial considerations, promotional activities, inherent genetic makeup and biological processes, emotional and mental states, alongside the effects of city development and existing structures.Individuals struggling with obesity frequently opt for intragastric balloons as a surgical alternative for weight management, achieved by the device physically filling stomach volume, thus fostering satiety and subsequently limiting the amount of food consumed.To illustrate this impact, data from the World Obesity Federation, a charitable entity based in the UK, presented in the World Obesity Atlas 2022 in March 2023, forecasts that the worldwide financial burden linked to being overweight and obese could escalate to an annual figure of $4.32 trillion by 2035 absent any modifications to current treatment and prevention strategies.Furthermore, projections indicate that by that same year, upwards of half the global inhabitants—specifically 51%, translating to over four billion persons—may be impacted by being overweight or obese, with approximately two billion people, equating to one in every four individuals, projected to meet the criteria for obesity should present trajectories persist.Consequently, the escalating rates of obesity serve as a key catalyst pushing the growth trajectory of the intragastric balloon market.

What Are The Major Segment Categories Driving The Intragastric Balloons Market Growth?

The intragastric balloonsmarket covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Trends Are Expected To Drive The Intragastric Balloons Market?

Leading firms within the intragastric balloon sector are currently concentrating efforts on innovating next-generation medical treatments for obesity, specifically the ingestible gastric balloon, aiming to substantially improve patient convenience, operational simplicity, and market availability. These orally administered gastric balloons represent non-invasive tools designed to assist in shedding weight by physically taking up volume within the stomach lining, thereby fostering satiety and consequently decreasing the quantity of food consumed. As an illustration, during September of 2022, the American medical technology firm Allurion Technologies Inc. introduced its swallowable gastric balloon capsule into the Indian market, marking the debut of the planet’s initial non-surgical, ingestible gastric balloon system that foregoes the necessity for endoscopic procedures or sedation during either implantation or explantation. The specialized gastric balloon offered by Allurion provides a secure, incisionless, and efficacious method for weight management, enabling people to attain meaningful reductions in body weight and cultivate sustainable healthy routines crucial for lasting positive outcomes.

Which Industry Leaders Are Driving Innovation Across The Intragastric Balloons Market?

Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd., American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc., Inamed Health, Medsil, Obalon Therapeutics Inc., Endalis, Lexel SRL

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Intragastric Balloons Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Browse Through More Reports Similar to the Global Intragastric Balloons Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastric Volvulus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Intragastric Balloons Market’s Growth Trajectory From 2025 To 2034?

The market size for intragastric balloons has seen a fast-paced increase recently. The market is projected to surge from $19.89 billion in 2024 to $22.05 billion in 2025, marking a compound annual growth rate (CAGR) of 10.9%. This substantial growth in the historic timeframe is due to factors such as the increase in obesity rates, higher healthcare spending, concrete clinical evidence, FDA approval milestones, public awareness efforts, enhancements in balloon design, and the rise in medical tourism.

The market size of intragastric balloons is predicted to experience a robust growth in the coming years, expected to reach $33.15 billion in 2029 with a CAGR of 10.7%. Factors contributing to this accelerated growth during the forecast period may include endorsements by celebrities, health problems associated with obesity, growth in emerging markets, an uptick in endoscopic procedures, an aging demographic, and customized treatment methods. Significant trends expected during the forecast period encompass technological advances, increased awareness via social media, collaboration with digital health platforms, the implementation of artificial intelligence, virtual patient consultations, and improved patient education initiatives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What are the Fundamental Drivers and Innovations Shaping the Intragastric Balloons Market?

The rising rates of obesity are anticipated to fuel the expansion of the intragastric balloon market. This term indicates the quantity or proportion of any given population that qualifies as obese based on a body mass index (BMI) of 30 or above. The escalation of these rates is attributed to factors like unhealthy food habits, lack of physical activity, economic influences, marketing and advertising strategies, genetic and biological factors, mental and emotional aspects, as well as urban development and infrastructure. Those suffering from obesity often turn to intragastric balloons as a non-invasive technique for weight loss as it takes up room in the stomach, stimulating satiety and cutting down food consumption. For instance, the World Obesity Atlas 2022, launched by the World Obesity Federation, a non-profit organization in the UK, stated in March 2023 that the global economic consequence of overweight and obesity is expected to hit $4.32 trillion a year by 2035, granted prevention and treatment methods stand still. By that year, more than half (51% or beyond 4 billion) of the world’s population could be affected by obesity or overweight, with almost 2 billion—a quarter of the total population—likely to struggle with obesity if the present trend persists. Thus, escalating obesity rates are a major driver for the growth of the intragastric balloon market.

How Is the Intragastric Balloons Market Segmented?

The intragastric balloonsmarket covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Which Regions Are Driving the Next Phase of the Intragastric Balloons Market Growth?

North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Intragastric Balloons Market?

Leading firms in the intragastric balloon market are centered on bringing innovative advancements to medical tools designed for weight loss, such as swallowable gastric balloons. These tools aim to improve patient comfort, simplicity, and availability. Swallowable gastric balloons are non-invasive devices designed to aid weight loss by temporarily filling some space in the stomach, thereby inducing a sense of satiety and reducing food consumption. In September 2022, Allurion Technologies Inc., a medical device firm based in the US, introduced a swallowable gastric balloon capsule to the Indian market. This is the first ever non-surgical, swallowable gastric balloon that eliminates the need for endoscopy or anesthesia during placement or removal. The Allurion gastric balloon capsule provides a safe, non-invasive, and efficient weight loss solution that assists people in achieving substantial weight loss and cultivating healthier lifestyle habits for sustainable success.

View the full report here:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

How Is the Intragastric Balloons Market Defined and What Are Its Core Parameters?

Intragastric balloons refer to a minimally invasive bariatric treatment for obesity that involves placing a medical implant in the stomach to restrict its capacity temporarily. This procedure is designed for individuals with obesity, offering a non-surgical option that does not require general anesthesia. The balloons work by taking up space in the stomach, making individuals feel full and limiting their food intake. They are typically inserted using an endoscope, a long, flexible tube with a camera attached, passed through the mouth into the stomach.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15835

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Intragastric Balloons Market Growth Performance Trended Historically, And What Lies Ahead?

Over the past few years, the size of the intragastric balloons market has seen a significant increase. It is projected to escalate from $19.89 billion in 2024 to a substantial $22.21 billion in 2025, bearing a compound annual growth rate (CAGR) of 11.7%. This growth during the historic period is largely due to factors such as the increase in obesity rates, the upsurge in healthcare spending, clinical proofs, FDA endorsements, awareness drives, advancements in balloon designs, and an expansion in medical tourism.

What Is the Forecast for the Intragastric Balloons Market Size Through 2029?

The market size of intragastric balloons is anticipated to experience swift expansion in the coming years, with an expected value of $34.23 billion in 2029 and a compound annual growth rate (CAGR) of 11.4%. Several factors contributing to this growth are celebrity endorsements, the prevalence of obesity-related health complications, growth in untapped markets, a rise in endoscopic procedures, a growing older population, and tailored treatment strategies. Noteworthy trends for the forecasting period involve technological advancements, social media awareness campaigns, the amalgamation with digital health platforms, implementation of artificial intelligence, the rise of virtual consultations, and improved patient education initiatives.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What are the Key Market Players in Intragastric Balloons Market and How They’re Evolving?

Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd., American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc., Inamed Health, Medsil, Obalon Therapeutics Inc., Endalis, Lexel SRL

What Are the Primary Growth Drivers in the Intragastric Balloons Market?

The rise in obesity rates is anticipated to stimulate the expansion of the intragastric balloon market. Obesity rates signify the portion of a population deemed obese based on body mass index (BMI) readings, generally categorized as having a BMI of 30 or above. This rise in obesity rates is attributed to factors such as sedentary lifestyle, dietary habits, economic circumstances, marketing and advertising, biology and genetics, psychological and mental influences, and urbanization and infrastructure. Intragastric balloons are employed by obese individuals as a non-operative method to assist in weight loss by filling stomach space, inducing satiety, and decreasing food consumption. For instance, the World Obesity Atlas 2022 from the World Obesity Federation, a non-profit organization based in the UK, reported in March 2023 that if prevention and therapy strategies remain stagnant, the worldwide economic impact of overweight and obesity could reach $4.32 trillion annually by 2035. By then, over half of the global population (51% or more than 4 billion individuals) could be impacted by overweight or obesity, with nearly 2 billion individuals—1 in 4 people—expected to be obese if the present trends persist. Consequently, the growing obesity rates are fueling the expansion of the intragastric balloon market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

What Are the Leading Segments in the Global Intragastric Balloons Industry?

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Are the Key Market Trends in the Intragastric Balloons Industry?

Major firms in the intragastric balloon market are concentrating their efforts on creating innovative advances in medical devices designed for weight loss, such as swallowable gastric balloons. These enhancements are geared at improving patient comfort, ease of use, and accessibility. Swallowable gastric balloons, non-surgical tools, assist in weight reduction by taking up temporary space within the stomach, creating a sensation of satiety, and cutting down on food consumption. Specifically, in September 2022, Allurion Technologies Inc., a medical device company based in the United States, introduced a swallowable gastric balloon capsule in India. This is the very first non-surgical swallowable gastric balloon in the world that doesn’t necessitate endoscopy or anesthesia for inserting or extracting. The Allurion gastric balloon capsule provides a safe, non-surgical, effective weight-loss solution, helping individuals successfully attain substantial weight loss and maintain healthy habits over the long run.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

What Is the Regional Outlook for the Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15835

This Report Delivers Insight On:

1. How big is the intragastric balloons market, and how is it changing globally?

2. Who are the major companies in the intragastric balloons market, and how are they performing?

3. What are the key opportunities and risks in the intragastric balloons market right now?

4. Which products or customer segments are growing the most in the intragastric balloons market?

5. What factors are helping or slowing down the growth of the intragastric balloons market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the intragastric balloons industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Intragastric Balloons Market Expected to Grow Between 2025 And 2029?

The market size for intragastric balloons has experienced a swift expansion in the past few years. Estimated to rise from a value of $19.89 billion in 2024, it is predicted to reach $22.21 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.7%. The upward trend in the historical period can be associated with factors like escalating rates of obesity, augmenting healthcare spending, clinical confirmations and FDA endorsements, public knowledge initiatives, advancements in balloon designs, and the surge in medical tourism.

The market size for intragastric balloons is projected to witness a swift expansion in the coming years. The value will reach $34.23 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.4%. The popularity of celebrity endorsements, health problems related to obesity, development in emerging markets, an uptick in endoscopic procedures, an older population, and the rise in tailored treatment strategies are all contributing to this forecasted growth. Key trends during this period comprise technological advances, increased awareness via social media, collaboration with digital health platforms, the use of artificial intelligence, virtual doctor visits, and improved patient education initiatives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Intragastric Balloons Market?

The surge in obesity rates is anticipated to fuel the expansion of the intragastric balloon market. Obesity rates denote the proportion or percentage of a population that meets the criteria for obesity based on body mass index (BMI) measurements, typically defined as a BMI of 30 or higher. The rise in obesity rates can be attributed to behaviors such as unhealthy eating habits, inactivity due to sedentary lifestyles, economic conditions, aggressive advertising and marketing strategies, genetic and biological factors, psychological and emotional issues, and advancements in urbanization and infrastructure. Intragastric balloons are often utilized by obese individuals as a non-surgical approach to weight loss, working by taking up space in the stomach, inducing a sense of fullness, and limiting food consumption. To illustrate, the World Obesity Atlas 2022, released by the non-profit organization World Obesity Federation based in the UK, stated in March 2023 that if preventative measures and treatments continue as they are, the global financial burden of overweight and obesity could escalate to $4.32 trillion annually by 2035. By this time, over half of the global population (51% or over 4 billion people) could be plagued by overweight or obesity issues. The prediction is that close to 2 billion people, equivalent to 1 in 4 individuals, could be living with obesity if current trends persist. As such, the escalating obesity rates are a significant driver in the growth of the intragastric balloon market.

How Is the Intragastric Balloons Market Segmented?

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons

2) By Filling Material: Saline Filled, Gas Filled

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon

2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon

3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Which Regions Are Key Players in the Growth of the Intragastric Balloons Market?

North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in the Intragastric Balloons Market Over the Coming Years?

Key players in the intragastric balloon market are focusing on the innovation of advanced medical weight-loss devices, such as ingestible gastric balloons, to improve patient comfort, usability, and accessibility. Ingestible gastric balloons are non-invasive devices used to aid weight loss by temporarily filling the stomach to induce satiety and reduce food consumption. For example, in September 2022, Allurion Technologies Inc., a medical device company based in the US, introduced an ingestible gastric balloon capsule to the Indian market. This product is the first of its kind worldwide, a non-surgical, ingestible gastric balloon that does not necessitate endoscopy or anesthesia during insertion or extraction. The Allurion gastric balloon capsule provides a secure, non-surgical, and practical solution for weight loss, enabling individuals to achieve significant weight loss and cultivate healthier lifestyle habits for sustained success.

View the full report here:

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

How Is the Intragastric Balloons Market Defined and What Are Its Core Parameters?

Intragastric balloons refer to a minimally invasive bariatric treatment for obesity that involves placing a medical implant in the stomach to restrict its capacity temporarily. This procedure is designed for individuals with obesity, offering a non-surgical option that does not require general anesthesia. The balloons work by taking up space in the stomach, making individuals feel full and limiting their food intake. They are typically inserted using an endoscope, a long, flexible tube with a camera attached, passed through the mouth into the stomach.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15835

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model